PROFIT RISE: CVS Caremark Corp. said Tuesday its third-quarter earnings climbed 25 percent, helped in part by generic drugs and revenue growth from both its pharmacy benefits management and drugstore businesses.

PROFIT RISE: CVS Caremark Corp. said Tuesday its third-quarter earnings climbed 25 percent, helped in part by generic drugs and revenue growth from both its pharmacy benefits management and drugstore businesses.

THE DETAILS: The Woonsocket, R.I., company earned $1.25 billion, or $1.02 per share. That compares with $1.01 billion, or 79 cents per share, last year. Revenue climbed nearly 6 percent to $31.97 billion. Adjusted earnings totaled $1.05 per share.

THE EXPECTATION: Analysts expected $1.02 per share on about $31.52 billion in revenue, according to FactSet.